Jan. 30 : Sigma-Aldrich , a leading $1.7 billion Life Science and High Technology Company, is pleased to announce it has launched Protease Finder, a novel Internet-based program expected to accelerate customers’ success

Jan. 25 : Sigma-Aldrich , a leading $1.7 billion Life Science Company and member of The RNAi Consortium (TRC), proudly welcomes the Vanderbilt-Ingram Cancer Center and the University of Michigan to the RNAi Partnership Program.

Jan. 23 : Sigma-Aldrich , a leading $1.7 billion Life Science and High Technology company, is pleased to launch the GenomePlex Tissue Whole Genome Amplification (WGA) Kit. This kit is the latest addition to the GenomePlex product line and includes all of the reagents needed for extraction and whole genome amplification from as little as [...]

Jan 16 : SAFC, a member of the Sigma- Aldrich Group , announced today that its SAFC Pharma business segment has been appointed by Affichem, a French biotechnology company, to provide chemical development services relating to Dendrogenine A, a potential cancer treatment.

Jan 03 : Sigma-Aldrich , a leading $1.7 billion Life Science and High Technology company, announced that it has granted Pfizer a worldwide non-exclusive research license to utilize DNA-directed RNAi (ddRNAi) technology.

Ablynx, the pioneer in the discovery and development of Nanobodies, a novel class of antibody-derived therapeutic proteins,

Sigma-Aldrich , a $1.7 billion Life Science and High Technology company, announced the release of the Universal Proteomics Standard during the HUPO Protein Test Sample Standards/NIST Workshop, an educational session prior to the HUPO 5th Annual World Congress. The standard, a complex mixture of 48 human proteins,

Sigma-Aldrich, a leading $1.7 billion Life Science company, is pleased to announce the latest addition to its Panorama(TM) Protein Array product line, the Panorama(TM) Human Kinase v1 Array. Developed in conjunction with Procognia Ltd, UK, and licensed exclusively through Sigma-Aldrich, the Kinase v1 protein array contains 152 commonly studied kinases.